Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study
Fei Shen, Bo Zhang, Fei Gao, Yingtao Lin et al.
Citations
2 citations
Journal
Frontiers in Immunology
Topics
Cancer Immunotherapy and Biomarkers
Field-Weighted Citation Impact (FWCI)
2.09
article
Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study
Fei Shen, Bo Zhang, Fei Gao, Yingtao Lin, Yi Zou, Dezhao Chen, Lele Zang, Yun Yi, Rong Lian, Renliang Fan, Haijuan Yu, Jieling Miao, Dan Hu, Jian‐Ping Zou, Li Liu, Jian Chen, Shaoyu Wang, Lin Yang, Yao Lin, Rong Lin, Xiaoying Weng, Wei Zeng, Qinrui Tian, Yuanfeng Chen, Yang Sun
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 16
Institutions
Fujian Medical University (CN), Jiangxi Provincial Cancer Hospital (CN), Ningde Normal University (CN), First Affiliated Hospital of Fujian Medical University (CN), Jiangxi Pingxiang People's Hospital (CN), Annoroad Gene Technology (China) (CN), Changsha Hospital for Maternal and Child Health Care (CN), Fujian Provincial Hospital (CN), Fujian Provincial Cancer Hospital (CN), Union Hospital (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study — Fei Shen, Bo Zhang, et al. · Frontiers in Immunology (2025) | TGRS Research Map | TGRS